A carregar...
Chimeric antigen receptor T cell therapy for pediatric and young adult B cell acute lymphoblastic leukemia
INTRODUCTION: Though 85% of children and young adults with acute lymphoblastic leukemia (ALL) are cured, the prognosis of relapsed or refractory disease is poor, with little progress made until recently. The advent of chimeric antigen receptor (CAR) T cell therapy has transformed treatment of relaps...
Na minha lista:
| Publicado no: | Expert Rev Clin Immunol |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7905709/ https://ncbi.nlm.nih.gov/pubmed/32975147 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/1744666X.2021.1828067 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|